5 Minutes Read

Quality of healthcare more vital than cost, says Devi Shetty

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

Dr Devi Shetty, chairman of Narayana Health, says “Low cost medicines are important. But quality is more important than the cost is.” Speaking to CNBC-TV18, he saidearly response has been good after the commissioning of 210 bed hospital in Gurugram, Haryana. Talking about the  KPME (Amendment) Bill 2017, he was of the view that nobody can accept the …

Dr Devi Shetty, chairman of Narayana Health, says “Low cost medicines are important. But quality is more important than the cost is.”

Speaking to CNBC-TV18, he saidearly response has been good after the commissioning of 210 bed hospital in Gurugram, Haryana.

Talking about the  KPME (Amendment) Bill 2017, he was of the view that nobody can accept the rules put forth by the Karnataka Government.

“Doctors give opinion based on the data that they have been provided and the similar data getting presented to different doctors can come up with different opinions. So subjecting the doctors under legal scrutiny with severe punishment is not good for the industry,” he said.

Senior politicians has the wisdom to accept our concern and they removed those clause, added Dr Shetty.

“India is a low cost healthcare destination and Indian medicines are the cheapest in the world. There is a limit to which one can push the price of a medicine,” he added.

 

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

April 23: Buy Kotak Mahindra Bank, IndusInd Bank, & Aurobindo Pharma, says Ashwani Gujral

Sensex, Nifty, Sensex today, Nifty today, share price, stock price movement, yes bank share price, Sensex lifetime high, Nifty liftime high, markets today, trading, stock tips today

The latest analysis and commentary by stock market guru Ashwani Gujral on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Kotak Mahindra Bank, IndusInd Bank, & Aurobindo Pharma.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

April 23: Buy Cadila Healthcare & Aurobindo Pharma, says Prakash Gaba

Top stocks

The latest analysis and commentary by stock market guru Prakash Gaba on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Cadila Healthcare & Aurobindo Pharma.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

April 23: Buy Ashok Leyland, Divis Lab, Godrej Industries, Tata Elxsi, & Wockhardt, says VK Sharma

buy sell stock ideas

The latest analysis and commentary by stock market guru VK Sharma of HDFC Securities on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Ashok Leyland, Divis Laboratories, Godrej Industries, Tata Elxsi, and Wockhardt.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Fortis deal turns out to be big

Fortis Healthcare deal is turning out to be one of the most interesting transactions the M&A space in India has ever seen. It not just has many interested bidders but is also talked about for the inadequate board and alleged fund diversion issues. With so much happening it makes for a perfect recipe for a spicy story.

Find out all about what’s happening at Fortis Healthcare in BIG DEAL. CNBC-TV18’s M&A specialist Nisha Poddar, who has been closely tracking all the developments and is credited with a lion share of deal breaks, gets the full picture in our weekly show BIG DEAL.

April 20: Buy Aurobindo Pharma, Sonata Software & Ashok Leyland, says Ashwani Gujral

CESC

The latest analysis and commentary by stock market guru Ashwani Gujral on what is moving the markets today.

He spoke at length about Aurobindo Pharma, Sonata Software & Ashok Leyland.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

April 20: Buy Biocon, Bharat Forge, Dr Reddys, says Prakash Gaba

market_stocks

The latest analysis and commentary by stock market guru Prakash Gaba on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Biocon, Bharat Forge, Dr Reddys Laboratories, and YES Bank.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

April 20: Buy Biocon, SAIL, & VA Tech Wabag, says Mitessh Thakkar

Stock market

The latest analysis and commentary by stock market guru Mitessh Thakkar on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Biocon, Kajaria Ceramics, Karnataka Bank, SAIL, and VA Tech Wabag.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.